This is a snippet of the transcript, sign up to read more.
I think part of it is due to negotiation and pricing. When you buy in bulk and add more products, the licensing costs can be more favorable. Another element is the trend to get everything more natively integrated. While everything can be integrated with everything, having tools like Power BI, ADO, a Microsoft-based CRM, and Office tools all from Microsoft offers more natural integration. So, I suspect the decision was driven by both cost and integration benefits.
This is a snippet of the transcript, sign up to read more.
Between Microsoft Project and Smartsheet, yes, mainly because of the need to have a license. Imagine, you know, I have a finance transformation project that takes, I don't know, six months or a year. Whatever it is, people are not accustomed to the tool, having to take a license and then drop it. Learning something that they will not use after that is a no-brainer. Then I use Smartsheet, which everyone can access and contribute to. Not just consume but also contribute. So if I tell them, "Look, this is your piece of the plan that you manage and update the status, update the dates, and keep it updated," and I'm just going to manage the overall project, it's a much easier tool. Even with the reminders and everything else, the mini automation that is built in, the trend is there.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research